Data repository for kidney diseases and related conditions
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
This study is collecting health information and samples from people with different kidney diseases to see how various factors affect their condition and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Rogosin Institute Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT01802034 on ClinicalTrials.gov |
What this trial studies
RENAL AID is an observational initiative aimed at collecting extensive data and biospecimens from individuals with various kidney diseases, including diabetic nephropathy and lupus nephritis. The study will link demographic, clinical, laboratory, and genetic information into a single electronic repository to uncover relationships between these data sets. By analyzing these connections, researchers hope to identify factors that predict disease progression and response to therapy, as well as non-invasive markers that correlate with renal biopsy findings. This comprehensive approach will facilitate a better understanding of kidney diseases and improve diagnostic methods.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with various kidney diseases, including those requiring a kidney biopsy or those with diabetes-related kidney issues.
Not a fit: Patients who are unable to provide informed consent or do not have any form of kidney disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved non-invasive diagnostic methods and better management of kidney diseases.
How similar studies have performed: Other studies utilizing similar data repository approaches have shown promise in identifying disease markers and improving patient outcomes, suggesting that this methodology is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Key Inclusion Criteria: All Groups: * Males or females * 18 years of age and older * Willing and able to provide informed consent Native Biopsy Tissue Group: \- Require an initial kidney biopsy for medical necessity Native Kidney, Non-tissue Group: * Previously had a kidney biopsy and the tissue is not stored in this biorepository; or * Have diabetes and kidney disease and have not had a kidney biopsy Allograft Tissue Group: \- Have undergone a renal transplant and require a transplant biopsy for either surveillance or "for-cause" indications. Key Exclusion Criteria for all Groups: \- Inability to provide informed consent.
Where this trial is running
New York, New York
- The Rogosin Institute — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Alan S Perlman, M.D. — The Rogosin Institute
- Study coordinator: Nelson Chen, M.A.
- Email: nec9039@nyp.org
- Phone: 646-317-0785
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.